N, G., & L, B. (2021). Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press.
Chicago Style (17th ed.) CitationN, Giustini, and Bazhenova L. Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press, 2021.
MLA (8th ed.) CitationN, Giustini, and Bazhenova L. Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.